Industry news that matters to you.  Learn more

Archives for November 2011

ILS and Stemina Biomarker Discovery Announce Exclusive Partnership for Human Stem Cell Based Toxicology Testing

Integrated Laboratory Systems (ILS) and Stemina Biomarker Discovery, Inc. announced today that the two companies have entered into a strategic partnership to advance the Stemina’s stem cell based toxicology testing platform, beginning with devTOX. ILS will exclusively distribute Stemina’s platform in North America and the two companies will work jointly to further develop the platform.

Rapid Technique Developed for Diagnosing Papillary Thyroid Cancer During Surgery

During surgical removal of thyroid tissue suspicious for cancer, fast, reliable, and cost-effective techniques are needed to analyze the resected tissue for biomarker — including BRAF V600E, a molecular biomarker for papillary thyroid cancer (PTC) — that can confirm the presence and type of cancer cells. Researchers have developed a new, rapid method for direct detection of the BRAF V600E gene in thyroid tissue without the need to purify DNA from tumor cells — high resolution melting analysis (HRM).

Johns Hopkins Researcher Wins Prize For Breast Cancer Biomarker Studies

A Johns Hopkins breast cancer researcher is the recipient of a $50,000 award designed to encourage rapid translation of her basic research on biomarkers into a commercially available test that could predict the best treatment options for some women with breast cancer.

Sara Sukumar, Ph.D., codirector of the Breast Cancer Program at the Sidney Kimmel Comprehensive Cancer Center, won one of two BioMaryland LIFE Prizes at the October 25 joint meeting of the Johns Hopkins University Alliance for Science and Technology Development and the University of Maryland Baltimore (UMB) Commercial Advisory Board.

Selventa and Linguamatics Announce Strategic Partnership to Provide a Complete Pipeline of Scientific Knowledge Extraction to their Life Science Partners

Selventa, a personalized healthcare company focused on stratification of patients and development of predictive biomarker panels based on disease-driving mechanisms, today announced that it has formed a strategic scientific alliance with Linguamatics, a software solutions company that provides knowledge extraction through its innovative I2E natural language processing (NLP) text mining platform. The alliance will bring together established analytical capabilities of both companies to efficiently extract complex life science knowledge in a computable, structured, biological expression language (BEL) format that can be used to interpret large-scale experimental data in the context of published literature.